The Valley Desk

NCT04729959 · Interventional trial

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Overall registry status Active not recruiting

Phase 2

Conditions Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov